8 Investor presentation First nine months of 2022 GLP-1 class expansion continues have accelerated in the third qua Weekly NBRx scripts (‘000s) 50 US GLP-1 weekly NBRx prescriptions 40 30 20 10 0 Oct 2020 Ozempic ® Rybelsus ® Victoza ® Oct 2022 NN GLP-1 du Source: IQVIA Xponent, Weekly (ending 14 Oct 2022) Each data points represents a rolling four-week average. Total GLP-1 scripts co NBRx: New-to-brand prescriptions; TRx: Total prescriptions; NN: Novo Nordisk; Scripts: Prescriptions Note: Class growth calculated as Q3 2022 vs Q3 2021
Download PDF file